Epidemiology of osteoporosis in rheumatic diseases

L Sinigaglia, M Varenna… - Rheumatic Disease …, 2006 - rheumatic.theclinics.com
Osteoporosis and related fragility fractures are one of the most common complications that
occur in patients who have rheumatic diseases, and they contribute to a dramatic decrease in …

A clinical overview of bone marrow edema

M Manara, M Varenna - Reumatismo, 2014 - reumatismo.org
Bone marrow edema (BME) is a descriptive term which identifies a specific magnetic resonance
imaging (MRI) pattern that can be observed in a number of clinical entities, which are …

Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study.

M Varenna, F Zucchi, D Ghiringhelli… - The Journal of …, 2000 - europepmc.org
Objective To evaluate the efficacy of intravenous (iv) clodronate in patients with reflex
sympathetic dystrophy syndrome (RSDS) and to assess the urinary excretion of type I collagen …

Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description.

…, M Pedrazzoni, M Rossini, M Varenna - Clinical and …, 2010 - europepmc.org
The threshold for pharmacological intervention for osteoporosis remains controversial. Tools
predicting the future risk of new fractures are increasingly used to establish a convenient …

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

L Valenti, M Varenna, AL Fracanzani, V Rossi… - Osteoporosis …, 2009 - Springer
In 87 patients with hereditary hemochromatosis, osteoporosis was detected in 25%, and
osteopenia in 41%. Bone mineral density was independently associated with BMI, ALP levels, …

Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study

M Varenna, S Adami, M Rossini, D Gatti… - …, 2013 - academic.oup.com
Objective. Complex regional pain syndrome type I (CRPS-I) is a severely disabling pain
syndrome for which no definite treatment has been established. The aim of this multi-centre, …

Prevalence of osteoporosis by educational level in a cohort of postmenopausal women

M Varenna, L Binelli, F Zucchi, D Ghiringhelli… - Osteoporosis …, 1999 - Springer
To evaluate whether the prevalence of osteoporosis and related risk factors might be influenced
by the level of education, as has been demonstrated for many other chronic diseases, …

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload.

…, L Binelli, N Battafarano, M Varenna… - The Journal of …, 1997 - europepmc.org
Objective To evaluate the frequency of arthropathy and osteoporosis in genetic
hemochromatosis (GH) and to quantify potential risk factors for these 2 conditions. Methods …

Intravenous pamidronate in the treatment of transient osteoporosis of the hip

M Varenna, F Zucchi, L Binelli, S Failoni, M Gallazzi… - Bone, 2002 - Elsevier
The aim of this study was to evaluate the efficacy of intravenous pamidronate in patients with
transient osteoporosis of the hip (TOH). Thirteen men and three women (mean age 38.3 …

Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study

M Varenna, F Zucchi, S Failoni, A Becciolini… - …, 2015 - academic.oup.com
Objective. The aim of this randomized, double-blind, placebo-controlled study was to assess
the efficacy of iv neridronate in controlling pain in patients with acute painful knee OA. …